Roche Polska Sp. z o.o. secures contract for Pharmaceutical products Delivery of a medicinal product containing the active substance Vemurafenib and Mosunetuzumab

Poland, March 20 -- Poland based Roche Polska Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products Delivery of a medicinal product containing the active substance Vemurafenib and Mosunetuzumab. The value of the contract is worth 34336280 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....